Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Research priorities regarding rotavirus vaccine and intussusception: a meeting summary.

Tate JE, Steele AD, Bines JE, Zuber PL, Parashar UD.

Vaccine. 2012 Apr 27;30 Suppl 1:A179-84. doi: 10.1016/j.vaccine.2011.08.110.

PMID:
22520129
2.

Workshop on intussusception in African countries--meeting report.

Steele AD, Patel M, Cunliffe NA, Bresee JS, Borgstein E, Parashar UD.

Vaccine. 2012 Apr 27;30 Suppl 1:A185-9. doi: 10.1016/j.vaccine.2011.10.004.

PMID:
22520130
3.

Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.

Desai R, Parashar UD, Lopman B, de Oliveira LH, Clark AD, Sanderson CF, Tate JE, Matus CR, Andrus JK, Patel MM.

Clin Infect Dis. 2012 May;54(10):1397-405. doi: 10.1093/cid/cis191.

4.

Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines.

Lloyd-Johnsen C, Justice F, Donath S, Bines JE.

Vaccine. 2012 Apr 27;30 Suppl 1:A190-5. doi: 10.1016/j.vaccine.2011.11.015.

PMID:
22520131
5.

Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.

Patel MM, Clark AD, Glass RI, Greenberg H, Tate J, Santosham M, Sanderson CF, Steele D, Cortese M, Parashar UD.

Vaccine. 2009 May 14;27(22):2916-22. doi: 10.1016/j.vaccine.2009.03.016.

PMID:
19428901
6.
7.

Intussusception and rotavirus vaccines: what is the background risk?

Sáez-Llorens X, Guevara JN.

Pediatr Infect Dis J. 2004 Apr;23(4):363-5.

PMID:
15071297
8.

Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009.

Yen C, Tate JE, Steiner CA, Cortese MM, Patel MM, Parashar UD.

J Infect Dis. 2012 Jul 1;206(1):41-8. doi: 10.1093/infdis/jis314.

9.

Rotavirus vaccines and intussusception risk.

Bines JE.

Curr Opin Gastroenterol. 2005 Jan;21(1):20-5. Review.

PMID:
15687880
10.

Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.

Laserson KF, Nyakundi D, Feikin DR, Nyambane G, Cook E, Oyieko J, Ojwando J, Rivers SB, Ciarlet M, Neuzil KM, Breiman RF.

Vaccine. 2012 Apr 27;30 Suppl 1:A61-70. doi: 10.1016/j.vaccine.2011.09.026.

PMID:
22520138
11.

Intussusception, infection, and immunization: summary of a workshop on rotavirus.

Kombo LA, Gerber MA, Pickering LK, Atreya CD, Breiman RF.

Pediatrics. 2001 Aug;108(2):E37.

PMID:
11483847
12.

Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico.

Velázquez FR, Colindres RE, Grajales C, Hernández MT, Mercadillo MG, Torres FJ, Cervantes-Apolinar M, DeAntonio-Suarez R, Ortega-Barria E, Blum M, Breuer T, Verstraeten T.

Pediatr Infect Dis J. 2012 Jul;31(7):736-44. doi: 10.1097/INF.0b013e318253add3.

PMID:
22695189
13.

Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program.

Carlin JB, Macartney KK, Lee KJ, Quinn HE, Buttery J, Lopert R, Bines J, McIntyre PB.

Clin Infect Dis. 2013 Nov;57(10):1427-34. doi: 10.1093/cid/cit520.

14.

Potential intussusception risk versus benefits of rotavirus vaccination in the United States.

Desai R, Cortese MM, Meltzer MI, Shankar M, Tate JE, Yen C, Patel MM, Parashar UD.

Pediatr Infect Dis J. 2013 Jan;32(1):1-7. doi: 10.1097/INF.0b013e318270362c.

PMID:
22929172
15.

Intussusception, rotavirus, and oral vaccines: summary of a workshop.

Peter G, Myers MG; National Vaccine Advisory Committee.; National Vaccine Program Office..

Pediatrics. 2002 Dec;110(6):e67.

PMID:
12456934
16.

Rotavirus vaccine and intussusception. Where do we go from here?

Dennehy PH, Bresee JS.

Infect Dis Clin North Am. 2001 Mar;15(1):189-207, x-xi. Review.

PMID:
11301815
17.

Intussusception-associated hospitalization among Venezuelan infants during 1998 through 2001: anticipating rotavirus vaccines.

Pérez-Schael I, Escalona M, Salinas B, Materán M, Pérez ME, González G.

Pediatr Infect Dis J. 2003 Mar;22(3):234-9.

PMID:
12634584
18.

Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines.

Parashar UD, Cortese MM, Payne DC, Lopman B, Yen C, Tate JE.

Am J Prev Med. 2015 Dec;49(6 Suppl 4):S377-82. doi: 10.1016/j.amepre.2015.09.005. Review.

PMID:
26590437
19.

An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?

Haber P, Chen RT, Zanardi LR, Mootrey GT, English R, Braun MM; VAERS Working Group..

Pediatrics. 2004 Apr;113(4):e353-9.

PMID:
15060267
20.

Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception.

Rothman KJ, Young-Xu Y, Arellano F.

J Infect Dis. 2006 Mar 15;193(6):898; author reply 898-9. No abstract available.

Items per page

Supplemental Content

Support Center